Efficacy and safety of anisodine hydrobromide injection in acute ischemic stroke—a multicenter real-world observational study
Bo Wu
ObjectiveTo evaluate the efficacy and safety of anisodine hydrobromide injection in patients with acute ischemic stroke in a real-world clinical setting.DesignMulticenter, real-world observational cohort study conducted from April 2018 to December 2021 with 90-day follow-up. Multivariable logistic regression and inverse probability of treatment weighting (IPTW) were applied.ParticipantsA total of 4,179 patients aged ≥18 years with acute ischemic stroke admitted within 30 days of onset were inclu